Safety of Intravenous Diltiazem in Reduced Ejection Fraction Heart Failure with Rapid Atrial Fibrillation

Clinical Drug Investigation
Mohamad Badr Jandali

Abstract

Diltiazem is a nondihydropyridine calcium channel blocker that is used to control rapid ventricular response in patients who have atrial fibrillation or flutter. Diltiazem has a negative inotropic effect and may cause hemodynamic decompensation in patients with reduced ejection fraction. This study evaluated outcomes in patients who had low ejection fraction and were treated with diltiazem. This was a retrospective chart review in 635 patients who were hospitalized because of rapid atrial fibrillation and who were treated with intravenous diltiazem. Outcomes were evaluated for patients in two groups based on ejection fraction (EF): normal (EF ≥ 50%) and low EF (EF < 50%). There were no differences in frequency of hypotension, intensive care unit transfer, or in-hospital mortality between the two groups. There was a significantly higher frequency of acute kidney injury within 48 h after starting diltiazem in patients who had low (16 patients [10%]) compared with normal EF (17 patients [3.6%] P = 0.002). Intravenous diltiazem in patients who have decreased EF may be associated with increased risk of acute kidney injury, but not increased risk of hypotension, intensive care unit transfer, or in-hospital mortality.

References

May 15, 1991·The American Journal of Cardiology·J T HeywoodK R Jutzy
Apr 15, 1990·The American Journal of Cardiology·M BöhmE Erdmann
Aug 18, 1988·The New England Journal of Medicine·UNKNOWN Multicenter Diltiazem Postinfarction Trial Research Group
Apr 1, 1984·Journal of the American College of Cardiology·R W WalshR A O'Rourke
Apr 1, 1981·British Heart Journal·P I JoshiA H Henderson
Jan 1, 1995·The American Journal of Cardiology·K A EllenbogenB S Stambler
Feb 24, 2001·Journal of the American College of Cardiology·S S ChughB J Gersh
Apr 3, 2003·The American Journal of Cardiology·William H Maisel, Lynne Warner Stevenson
Aug 9, 2007·European Journal of Clinical Pharmacology·Pär HallbergUNKNOWN RIKS-HIA group
Nov 29, 2012·European Heart Journal·Matthew G WhitbeckClaude S Elayi
Nov 22, 2014·Circulation. Arrhythmia and Electrophysiology·James V FreemanAlan S Go

❮ Previous
Next ❯

Citations

Nov 16, 2020·The American Journal of Emergency Medicine·Jessica NicholsonKelsey Billups

❮ Previous
Next ❯

Related Concepts

Related Feeds

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Atrial Filbrillation

Atrial fibrillation refers to the abnormal heart rhythm characterized by rapid and irregular beating of the atria. Here is the latest research.